The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Psiquiatria
2005
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1516-44462005000100007 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1516-444620050001000072005-04-14The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysisSchmitt,RicardoGazalle,Fernando KratzLima,Maurício Silva deCunha,ÂngeloSouza,JulianoKapczinski,Flávio Anxiety disorders/drug therapy Antidepressive agents/therapeutic use Randomized controlled trials Review, academic [Publication type] Meta-analysis OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context.info:eu-repo/semantics/openAccessAssociação Brasileira de PsiquiatriaBrazilian Journal of Psychiatry v.27 n.1 20052005-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007en10.1590/S1516-44462005000100007 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Schmitt,Ricardo Gazalle,Fernando Kratz Lima,Maurício Silva de Cunha,Ângelo Souza,Juliano Kapczinski,Flávio |
spellingShingle |
Schmitt,Ricardo Gazalle,Fernando Kratz Lima,Maurício Silva de Cunha,Ângelo Souza,Juliano Kapczinski,Flávio The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
author_facet |
Schmitt,Ricardo Gazalle,Fernando Kratz Lima,Maurício Silva de Cunha,Ângelo Souza,Juliano Kapczinski,Flávio |
author_sort |
Schmitt,Ricardo |
title |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
title_short |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
title_full |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
title_fullStr |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
title_full_unstemmed |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
title_sort |
efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis |
description |
OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context. |
publisher |
Associação Brasileira de Psiquiatria |
publishDate |
2005 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007 |
work_keys_str_mv |
AT schmittricardo theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT gazallefernandokratz theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT limamauriciosilvade theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT cunhaangelo theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT souzajuliano theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT kapczinskiflavio theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT schmittricardo efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT gazallefernandokratz efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT limamauriciosilvade efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT cunhaangelo efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT souzajuliano efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis AT kapczinskiflavio efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis |
_version_ |
1756422575149285376 |